Simudyne
PrivateLast Round
Series A
Apr 8, 2019
Est. Valuation
$16.1M
Total Funding Raised
$12.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Simudyne operates in Enterprise Software and is based in London. Its latest recorded funding round was a Series A round in April 2019.
Simudyne is a software company that provides an enterprise simulation platform using agent-based modeling and AI for financial institutions to test decisions and manage risk.
Sector
Enterprise Software
Verticals
Compliance & Risk, Business Intelligence, Financial Data, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simudyne Comparables
Compare Simudyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quantum Technology Solutions Limited | 77% | |
| Cosmo Tech | 74% | |
| Epistemix | 70% |
For institutional investors. Book with your work email.
Simudyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 8, 2019 | ||||
| Accelerator | Oct 2, 2018 | ||||
| Seed | Feb 16, 2018 | ||||
| Accelerator | May 3, 2017 | ||||
| Accelerator | Dec 11, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Simudyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Barclays PLC | Series A |
| CyLon | Accelerator |
| Techstars | Accelerator, Seed |
| Calibrate Ventures | Seed |
| Barclays Accelerator | Accelerator |
| Sway Ventures | Seed |
| Graphene Ventures | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 35% QoQ, from 17 to 23 employees.
- Jul 23, 2026
Grew 24% QoQ, from 17 to 21 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 5, 2026
Simudyne is developing advanced market simulation capabilities for capital markets participants in partnership with BMLL, combining historical order book data with generative AI and agent-based simulation to enable realistic market simulations, trading-session replays, and reactive back-testing on Oct 5th '26.
- is_developingSep 30, 2026
Simudyne has begun training generative AI Large Market Models using granular market data to generate synthetic tick data and support client-specific fine-tuning alongside its established rule-based agent-based modelling capabilities.
- partners_withSep 30, 2026
Simudyne and BMLL partner to power Large Market Models for intraday trading, execution, and risk using Level 2 and Level 3 market data, with new modules planned for the Pulse simulation platform.
For institutional investors. Book with your work email.
Simudyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Simudyne's valuation, stock price, and market status.
Is Simudyne a public or private company?
Simudyne is a private company.
What is the current stock price of Simudyne?
Simudyne is a private company, so its shares have no public market price. Caplight tracks Simudyne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Simudyne worth (valuation)?
Simudyne's valuation is estimated at $16.1M based on funding round data.
Can I buy Simudyne stock?
Simudyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Simudyne's last funding round?
Simudyne's most recent funding round was Series A on April 8, 2019.
Who are the main investors in Simudyne?
Key investors in Simudyne include Barclays PLC, CyLon, Calibrate Ventures.
Will Simudyne IPO soon?
No public IPO plans have been announced for Simudyne.
How can I track Simudyne secondary market activity?
Caplight tracks bids, offers, and trades in Simudyne's shares on secondary markets.